SCHEMBL7652829

SCHEMBL7652829

O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)cc1)C(c1ccccc1)c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.64
GRM4 Q14833 1/20 0.60
POLB P06746 3/20 0.58
KMT2A Q03164 2/20 0.58
HPGD P15428 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.54
USP2 O75604 1/20 0.54
MAPT P10636 1/20 0.54
TSHR P16473 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
HSD17B10 Q99714 1/20 0.54
KDM4E B2RXH2 1/20 0.54
RECQL P46063 1/20 0.54
HTT P42858 1/20 0.53
ALDH1A1 P00352 1/20 0.52
MEN1 O00255 1/20 0.52
SCN1A P35498 1/20 0.52
SCN4A P35499 1/20 0.52
SCN5A Q14524 1/20 0.52
SCN9A Q15858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31238045 0.82 LMNA (0.55) LMNAGRM4POLBKMT2AHPGD
SCHEMBL7657605 0.80 POLB (0.51) LMNAPOLBKMT2ASMN1; SMN2USP2
Bicarbonate SCHEMBL15225914 0.78 SMN1; SMN2 (0.70) LMNAGRM4POLBKMT2AHPGD
Bicarbonate SCHEMBL15226101 0.78 KMT2A (0.66) LMNAGRM4KMT2AHPGDSMN1; SMN2
SCHEMBL4067862 0.78 KMT2A (0.69) LMNAGRM4KMT2AHPGDSMN1; SMN2
SCHEMBL8396710 0.77 SMN1; SMN2 (0.78) LMNAKMT2AHPGDSMN1; SMN2MAPT
SCHEMBL812698 0.77 SMN1; SMN2 (0.78) LMNAKMT2AHPGDSMN1; SMN2MAPT
SCHEMBL11707518 0.77 SMN1; SMN2 (0.78) LMNAKMT2AHPGDSMN1; SMN2MAPT
SCHEMBL4067788 0.76 KMT2A (0.68) LMNAGRM4KMT2AHPGDSMN1; SMN2
SCHEMBL7655884 0.76 KMT2A (0.71) LMNAKMT2AUSP2MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407120-B1 ADMINISTERING PYRIDINYLACETAMIDE OR PHENYLACETAMIDE DERIVATIVE TO TREAT CARDIOVASCULAR, EATING, SEXUAL, BRAIN, NERVOUS SYSTEM, GASTROINTESTINAL, UROGENITAL, PSYCHOLOGICAL, AND RESPIRATORY SYSTEM DISORDERS PFIZER INC. 2002-06-18 US disclosed